Sarepta Therapeutics Inc (NASDAQ: SRPT) on Tuesday, soared 1.64% from the previous trading day, before settling in for the closing price of $117.79. Within the past 52 weeks, SRPT’s price has moved between $55.25 and $173.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 32.89% over the past five years. The company achieved an average annual earnings per share of 135.78%. With a float of $89.52 million, this company’s outstanding shares have now reached $93.73 million.
Let’s look at the performance matrix of the company that is accounted for 1314 employees. In terms of profitability, gross margin is 87.71%, operating margin of 2.52%, and the pretax margin is 4.13%.
Sarepta Therapeutics Inc (SRPT) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Sarepta Therapeutics Inc is 6.13%, while institutional ownership is 92.35%. The most recent insider transaction that took place on Aug 30 ’24, was worth 822,100. In this transaction Chief Financial Officer of this company sold 5,985 shares at a rate of $137.36, taking the stock ownership to the 33,946 shares. Before that another transaction happened on Aug 30 ’24, when Company’s Officer proposed sale 5,985 for $137.37, making the entire transaction worth $822,130.
Sarepta Therapeutics Inc (SRPT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 135.78% per share during the next fiscal year.
Sarepta Therapeutics Inc (NASDAQ: SRPT) Trading Performance Indicators
Sarepta Therapeutics Inc (SRPT) is currently performing well based on its current performance indicators. A quick ratio of 3.19 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.40, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 11.22 in one year’s time.
Technical Analysis of Sarepta Therapeutics Inc (SRPT)
Sarepta Therapeutics Inc (NASDAQ: SRPT) saw its 5-day average volume 0.96 million, a negative change from its year-to-date volume of 1.27 million. As of the previous 9 days, the stock’s Stochastic %D was 20.18%. Additionally, its Average True Range was 3.67.
During the past 100 days, Sarepta Therapeutics Inc’s (SRPT) raw stochastic average was set at 15.49%, which indicates a significant decrease from 25.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.94% in the past 14 days, which was lower than the 55.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $131.65, while its 200-day Moving Average is $128.54. Nevertheless, the first resistance level for the watch stands at $121.23 in the near term. At $122.74, the stock is likely to face the second major resistance level. The third major resistance level sits at $124.59. If the price goes on to break the first support level at $117.87, it is likely to go to the next support level at $116.02. The third support level lies at $114.51 if the price breaches the second support level.
Sarepta Therapeutics Inc (NASDAQ: SRPT) Key Stats
Market capitalization of the company is 11.42 billion based on 94,524K outstanding shares. Right now, sales total 1,243 M and income totals -535,980 K. The company made 362,930 K in profit during its latest quarter, and 6,460 K in sales during its previous quarter.
